Covalon Technologies (OTCMKTS:CVALF) Stock Price Up 0.5% – What’s Next?

Shares of Covalon Technologies Ltd. (OTCMKTS:CVALF) traded up 0.5% during mid-day trading on Tuesday . The company traded as high as $2.24 and last traded at $2.22. 22,853 shares changed hands during mid-day trading, an increase of 63% from the average session volume of 14,008 shares. The stock had previously closed at $2.21.

Covalon Technologies Stock Performance

The stock’s fifty day moving average is $2.32 and its two-hundred day moving average is $1.63. The firm has a market cap of $56.53 million, a price-to-earnings ratio of -24.94 and a beta of -0.36.

Covalon Technologies (OTCMKTS:CVALF) last posted its quarterly earnings data on Wednesday, August 21st. The company reported $0.04 EPS for the quarter. Covalon Technologies had a negative return on equity of 4.40% and a negative net margin of 2.94%. The company had revenue of $6.74 million for the quarter.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.